Jerome Freeman, MD
Neurology · Sioux Falls, SDNPI 1609899665
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $214 and has fallen 59.6% since, to $86 in 2025. That places this record below the midpoint for neurology clinicians in SD, where the typical reported total is $732.
Across 20 payments — averaging $19.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$74
- Sanofi$68
- Novartis$66
- Supernus Pharmaceuticals, Inc.$47
- EMD Serono, Inc.$33
- Averitas Pharma Inc.$22
- plus $78 from 5 others
What the payments were for
- Food & beverage$388100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 3 | $74 |
| Sanofi | 1 | $68 |
| Novartis | 5 | $66 |
| Supernus Pharmaceuticals, Inc. | 3 | $47 |
| EMD Serono, Inc. | 2 | $33 |
| Averitas Pharma Inc. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Biogen | 1 | $17 |
| Tanabe Pharma America, Inc. | 1 | $15 |
| Bristol Myers Squibb | 1 | $14 |
| Pfizer | 1 | $14 |
How this compares
$388 in reported general payments places this provider in the 30th percentile of 49 neurology providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CopaxoneGlatiramer Acetate | 25 | $140,384 |
| LamictalLamotrigine | 12 | $10,526 |
| Carbamazepine ErCarbamazepine | 66 | $7,898 |
| Levetiracetam | 241 | $7,241 |
| Lacosamide | 60 | $6,462 |
| Divalproex Sodium ErDivalproex Sodium | 110 | $6,147 |
| Carbamazepine | 72 | $4,346 |
| Pregabalin | 32 | $3,718 |
| Oxcarbazepine | 15 | $1,945 |
| Gabapentin | 144 | $1,927 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 81 | $1,850 |
| Memantine Hcl | 107 | $1,711 |
| Pyridostigmine Bromide | 28 | $1,098 |
| Baclofen | 82 | $1,063 |
| Donepezil Hcl | 129 | $1,043 |
Paid to pharmacies, not to this prescriber.
Other neurology in Sioux Falls
- Andrew RidderSioux Falls$97K
- Wijdan RaiSioux Falls$81K
- Jeffrey BoyleSioux Falls$14K
- Mehwish FarooqiSioux Falls$12K
- Bassel SalemSioux Falls$7K
- Cynthia Zevallos MauSioux Falls$6K
- Karan TopiwalaSioux Falls$4K
- Jorge SanchezSioux Falls$3K
- Nessim AminSioux Falls$1K
- Lisa ViolaSioux Falls$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.